Amar A. Sethi M.D.

Amar A. Sethi, MD. PhD. has extensive work experience in the field of clinical development and medical research. Amar A. currently holds the position of Associate Vice President of Clinical Development at Omeros Corporation since 2019, where they lead a pivotal global Phase 3 clinical program for a biologic drug designated as Breakthrough Therapy and Orphan Drug by the FDA. Amar A. is responsible for managing relationships with key opinion leaders and principal investigators, as well as driving strategic initiatives associated with advisory boards and biomarker advisory groups.

Prior to their current role, Dr. Sethi served as Sr. Medical Director of Clinical Development at Omeros Corporation from 2019 to 2020, where they led the same Phase 3 clinical program and was responsible for managing relationships with key opinion leaders and principal investigators, as well as driving strategic initiatives associated with advisory boards and biomarker advisory groups.

Before joining Omeros Corporation, Dr. Sethi held significant roles at Pacific Biomarkers from 2009 to 2019. Amar A. served as President and Chief Medical Officer from 2015 to 2019, where they defined and drove company strategy, led cross-functional teams, and managed the company's P&L. Amar A. also served as Chief Scientific Officer from 2011 to 2015, where they established a strong presence for the company in the field of bioanalytical sciences and developed novel biomarker portfolios. Additionally, they held the position of Vice-President of Science and Technology from 2009 to 2011, where they led laboratory services and employed new technologies.

Earlier in their career, Dr. Sethi worked at the National Institutes of Health from 2005 to 2009, where they completed a Clinical Chemistry Fellowship and served as a Postdoctoral Scientist. During their time at the NIH, they led the immunology section and conducted research on dysfunctional HDL particles in patients with ischemic heart disease.

Dr. Sethi began their career at Rigshospitalet in 1996, where they worked as a Staff Physician and Senior Registrar. During this time, they completed their residency and a 6-year specialization program to become a Board Certified Clinical Biochemist. Amar A. worked in various departments of laboratory medicine, overseeing sections such as chemistry, immunology, genetic testing, coagulation, and hematology.

Overall, Dr. Amar A. Sethi has a vast and diverse work experience ranging from clinical development in the biopharmaceutical industry to medical research and laboratory medicine.

Amar A. Sethi, MD, PhD, has an extensive education history. Amar A. obtained a Doctor of Philosophy (PhD) degree in the field of Genetics of Hypertension, Ischemic Heart Disease, and Ischemic Cerebrovascular Disease from Københavns Universitet - University of Copenhagen. Additionally, they hold a Doctor of Medicine (MD) degree from the same institution.

In terms of additional certifications, Sethi has obtained a Certification in Pathology, specifically Chemical Pathology (Clinical Biochemistry), from the National Board of Health Denmark. Amar A. also holds a Physician certification from the same institution.